Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients

Journal of Viral Hepatitis

Volumn 18, Issue 10, 2011, Pages 685-691

  Sanchez Conde M ^a   Miralles, P ^a   Maria Bellon J ^b   Rincon D ^c   Ramirez M ^a   Gutierrez I ^a   Ripoll, C ^c   Lopez J C ^a   Cosin J ^a   Clemente, G ^c   Lo Iacono, O ^c   Banares R ^c,d   Berenguer, J ^a  

^a Infectious Diseases   (Spain)

^b Biomedical Research Foundation   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

hepatitis C infection; HIV infection; liver cirrhosis; liver pathology

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ELASTOGRAPHY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMODYNAMIC PARAMETERS; HEPATIC VENOUS PRESSURE GRADIENT; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER BIOPSY; LIVER FIBROSIS; MALE; NON INVASIVE PROCEDURE; PORTAL HYPERTENSION; PORTAL VEIN; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; VENOUS PRESSURE; VIRUS HEPATITIS;

ADULT; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; HYPERTENSION, PORTAL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 80052843665     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01371.x     Document Type: Article

References (44)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338 (13): 853-860. (Pubitemid 28135961)
2. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26 (1): 1-5. (Pubitemid 27072597)
3. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001; 33 (4): 562-569. (Pubitemid 32709592)
4. Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G,. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Clin Infect Dis 2001; 32 (8): 1207-1214. (Pubitemid 32381124)
5. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32 (3): 492-497. (Pubitemid 32173638)
6. Martinez-Sierra C, Arizcorreta A, Diaz F, et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003; 36 (4): 491-498. (Pubitemid 36241318)
7. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30 (4): 1054-1058. (Pubitemid 29458296)
8. Mohsen AH, Easterbrook PJ, Taylor C, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003; 52 (7): 1035-1040. (Pubitemid 36765298)
9. Ragni MV, Belle SH,. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 2001; 183 (7): 1112-1115. (Pubitemid 32230961)
10. Thomas DL,. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002; 5 (Suppl. 1): S201-S209. (Pubitemid 35253482)
11. Munshi N, Balasubramanian A, Koziel M, Ganju RK, Groopman JE,. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 2003; 188 (8): 1192-1204. (Pubitemid 37338984)
12. Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41 (4): 779-789. (Pubitemid 40462940)
13. Lo Iacono O, Berenguer J, Rincõn D, Miralles P, Hernando A, Sánchez-Conde M, et al. Hepatic venous pressure gradient (HVPG) is lower in HIV/HCV-coinfected than in HCV-monoinfected cirrhotic patients. 15th Conference on Retroviruses and Opportunistic Infections. Boston, February 3-6. 2008; P-1064.
14. Bosch J, Navasa M, Garcia-Pagan JC, DeLacy AM, Rodes J,. Portal hypertension. Med Clin North Am 1989; 73 (4): 931-953. (Pubitemid 19163732)
15. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R,. The Portal Hypertension Collaborative Group. Hepatic venous pressure gradient (HVPG) predicts clinical decompensation in patients with compensated cirrhosis. Hepatology 2006; 44 (Suppl.): 203A.
16. Lawson A, Hagan S, Rye K, et al. The natural history of hepatitis C with severe hepatic fibrosis. J Hepatol 2007; 47 (1): 37-45. (Pubitemid 46817690)
17. van Leeuwen DJ, Howe SC, Scheuer PJ, Sherlock S,. Portal hypertension in chronic hepatitis: relationship to morphological changes. Gut 1990; 31 (3): 339-343. (Pubitemid 20093676)
18. Burroughs AK, Groszmann R, Bosch J, et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut 2002; 50 (3): 425-427. (Pubitemid 34161063)
19. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29 (12): 1705-1713. (Pubitemid 38091720)
20. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41 (1): 48-54. (Pubitemid 40066382)
21. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128 (2): 343-350. (Pubitemid 40439195)
22. de Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006; 41 (2): 175-179.
23. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55 (3): 403-408. (Pubitemid 43268281)
24. Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45 (5): 1290-1297. (Pubitemid 46775793)
25. Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008; 27 (12): 1261-1268. (Pubitemid 351697282)
26. de Franchis R,. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008; 49 (4): 520-527.
27. Kazemi F, Kettaneh A, N'Kontchou G, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45 (2): 230-235.
28. Castera L, Le Bail B, Roudot-Thoraval F, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50 (1): 59-68.
29. Lucidarme D, Foucher J, Le Bail B, et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49 (4): 1083-1089.
30. Castera L, Forns X, Alberti A,. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48 (5): 835-847.
31. Groszmann RJ, Wongcharatrawee S,. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004; 39 (2): 280-282. (Pubitemid 38222164)
32. de Franchis R,. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33 (5): 846-852.
33. Colombo M, Del Ninno E, de Franchis R, et al. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology 1988; 95 (2): 487-489.
34. Banares R, Alonso S, Catalina MV, et al. Randomized controlled trial of aspiration needle versus automated biopsy device for transjugular liver biopsy. J Vasc Interv Radiol 2001; 12 (5): 583-587. (Pubitemid 32423067)
35. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24 (2): 289-293. (Pubitemid 26260021)
36. de Franchis R, Pascal JP, Ancona E, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992; 15 (1-2): 256-261.
37. Thabut D, Simon M, Myers RP, et al. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 2003; 37 (5): 1220-1221; author reply 1221.
38. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43 (6): 1317-1325. (Pubitemid 43980111)
39. Berenguer J, Bellon JM, Miralles P, et al. Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data. J Viral Hepat 2007; 14 (12): 859-869. (Pubitemid 350211409)
40. Cacoub P, Carrat F, Bedossa P, et al. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study-ANRS HC02. J Hepatol 2008; 48 (5): 765-773.
41. Castera L, Pawlotsky JM,. Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C. Med Gen Med 2005; 7 (4): 39.
42. Vergara S, Macias J, Rivero A, et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2007; 45 (8): 969-974. (Pubitemid 47580344)
43. Sanchez Antolin G, Garcia Pajares F, Vallecillo MA, et al. FibroScan evaluation of liver fibrosis in liver transplantation. Transplant Proc 2009; 41 (3): 1044-1046.
44. Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 2006; 20 (1): 49-57. (Pubitemid 41818114)